0
     

Report Added
Report already added
Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

Report Scope

The report focuses on select drugs (antimicrobials), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (e.g., catheters, patient ventilation devices, sterile IV filters) that prevent the occurrence of nosocomial infections.

Within each type of treatment, regional analyses will focus on the Americas (i.e., Canada, the U.S., Mexico, Central America and South America), EMRA (i.e., Europe, the Middle East, Russia and Africa) and Asia-Pacific (i.e., Japan, China, India, other Western Pacific countries such as Australia and New Zealand, and other Southeast Asian countries).

Report Includes

- 72 tables
- An updated review of the global healthcare-acquired infection (HCAI)-control market
- Analyses of the global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of select antimicrobials drugs and environment sterilization/disinfection products currently used or under development for treatment of healthcare-associated infections
- Market outlook and forecast trends of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent the occurrence of nosocomial infections
- Estimation of the market size and revenue forecasts for HCAI-control market, and corresponding market share analysis by key market segments — technology type, application, and geography
- Discussion of the key market dynamics, industry structure, regulatory approval, market deterrents, unmet needs and other factors driving opportunities in microbiology research
- A look at the pipeline products for antimicrobial resistance (AMR), hospital surveillance methods and tools used to control HCAI infections
- Review of the U.S. patent grants for innovations in infectious diseases control and viral infections
- Profile descriptions of the leading industry players including 3M, Merck, Novartis’, Pfizer, Roche, and Sanofi
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
Healthcare-Acquired Infections
Types of Infections
Central-Line-Associated Bloodstream Infections
Surgical Site Infections
Catheter-Associated Urinary Tract Infections
Ventilator-Associated Pneumonia
Diseases and Infectious Agents in Healthcare Settings
Acinetobacter
Burkholderia Cepacia
Clostridium Difficile
Clostridium Sordellii
Enterobacteriaceae (Carbapenem-Resistant)
Gram-Negative Bacteria
Hepatitis
HIV/AIDS
Influenza
Klebsiella
Methicillin-Resistant Staphylococcus aureus
Mycobacterium Abscessus
Norovirus
Pseudomonas Aeruginosa
Staphylococcus Aureus
Vancomycin-Resistant Enterococci
Incidence and Prevalence
Risk Factors
Prevention Strategies
Basic Infection Prevention and Control
Antibiotics and Multidrug-Resistant Organisms
Device-Associated Infection Control
Procedure-Associated Guidelines
Setting Specific Guidelines
WHO Guidelines
Surveillance Systems
Chapter 4 Market Summary and Analysis
Global Market for Infection Control
Regional Analysis
Market Drivers
Antimicrobial Resistance
Increasing Population and Demographic Changes
Emerging Markets
New Technologies
Vaccine Coverage
Increase in Focus on HCAIs
Market Deterrents
Cost-Effectiveness of Newer Methods
Unmet Needs
Effective Treatment for "Superbugs"
Chapter 5 Pharmaceuticals
HCAI Pharmaceutical Market
Antibiotics
Mechanism of Action
Antibiotic Resistance
Mechanisms of Antibiotic Resistance
Reasons for Antibiotic Resistance
Antimicrobial Resistance (Antibiotics): Incidence
Antibiotic Resistance: Hospitals and Healthcare Settings
Davos Declaration for Combating Antimicrobial Resistance
Antibiotics for Bacterial HCAIs
Select Marketed Antibiotics
Global Market for Antibiotics
Antifungal Drugs
Antifungals for HCAI
Select Marketed Antifungals
Global Market for Antifungals
Antivirals and Vaccines
Hepatitis B and Hepatitis C
Influenza
Chapter 6 Environmental Treatment
HCAI: Environmental Treatment Market
Disinfectants
Types
Key Marketed Hospital-Use Disinfectants
Patient Skin Preparation
Key Marketed Patient Skin Preparation Antiseptics
Patient Skin Preparation Market
Environment Sterilization
Air Treatment
Room Filtration Systems
Room Pressurization
UV Light Disinfection
Water Treatment
Equipment/Facility Sterilization
Heat Sterilization
Chemical Sterilization
Radiation-Based Sterilization
Environment Sterilization Market
Chapter 7 Medical Devices
HCAI Medical Device Market
Antimicrobial Coatings
Catheters
Patient Ventilation Devices
Types
Treatments and Devices
IV Filters
IV Filter Market
Chapter 8 Industry Structure
Industry Structure for Healthcare Infection Prevention
Suppliers
Customers
Consumers
Chapter 9 Research and Opportunities
New Technologies
Hand Hygiene
Patient Tracing
Self-Disinfecting Surfaces
Automated Decontamination Technologies
Smart Systems and Predictive Analytics
Other Technologies
Antibiotics Pipeline
Viral Infection Pipeline: Hepatitis B Treatments
Pipeline of Viral Infection Influenza Treatments
Fungal Infection Treatment Pipeline
Chapter 10 Patent/Patent Application Analysis
Pharmaceuticals
Antibiotics
Hepatitis B Treatments
Hepatitis C Treatments
Influenza Treatments
Antifungal Treatments
Environment Sterilization
Disinfectants
Patient Skin Preparation Treatments
Air Treatment Technologies
Water Treatment Technologies
Medical Devices
Catheters and Endotracheal Tubes
IV Filters (In-Line)
Chapter 11 Company Profiles
Pharmaceutical Companies
GILEAD SCIENCES
MERCK
NOVARTIS
PFIZER
ROCHE
SANOFI PASTEUR
SEQIRUS
Companies in Sterilization/Disinfection Industry
3M HEALTHCARE
ADVANCED STERILIZATION PRODUCTS
BECTON, DICKINSON AND COMPANY
BELIMED
THE CLOROX COMPANY
STERIGENICS
XENEX DISINFECTION SERVICES
Medical Device Companies
BACTIGUARD
TELEFLEX
Chapter 12 Appendix

Report Title: Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW